Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394518
Status:
COMPLETED
Last Update Posted:
2024-05-01
First Post:
2024-04-27
Brief Title:
Phase 1 Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants
Sponsor:
TenNor Therapeutics Inc
Organization:
TenNor Therapeutics Inc
Organization Data
Organization:
TenNor Therapeutics Inc
Class:
INDUSTRY
Study ID:
TNP-2092-IV-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TenNor Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None